A Safety and Efficacy Study of Fabrazyme® Replacement Therapy in Patients With Cardiac Fabry Disease
Clinical trial NCT00140621 · COMPLETED
Trial details
- NCT number
- NCT00140621
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2012-08-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.